was read the article
array:21 [ "pii" => "X2013251411052463" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Aug.11119" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:607-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3535 "formatos" => array:3 [ "EPUB" => 287 "HTML" => 2783 "PDF" => 465 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699511052466" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2011.Aug.11119" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2011;31:607-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5697 "formatos" => array:3 [ "EPUB" => 288 "HTML" => 4910 "PDF" => 499 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Respuesta al comentario sobre el Manejo de la infección por el virus de la hepatitis C en la enfermedad renal crónica" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "607" "paginaFinal" => "608" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Response to the comment made on Treatment of HCV infection in chronic kidney disease" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rebeca García Agudo, R. García Agudo, Sami Aoufi Rabih, S. Aoufi Rabih" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Rebeca" "apellidos" => "García Agudo" ] 1 => array:2 [ "Iniciales" => "R." "apellidos" => "García Agudo" ] 2 => array:2 [ "nombre" => "Sami" "apellidos" => "Aoufi Rabih" ] 3 => array:2 [ "Iniciales" => "S." "apellidos" => "Aoufi Rabih" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251411052463" "doi" => "10.3265/Nefrologia.pre2011.Aug.11119" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052463?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511052466?idApp=UINPBA000064" "url" => "/02116995/0000003100000005/v0_201502091408/X0211699511052466/v0_201502091409/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251411052455" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Jun.10942" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:608-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3429 "formatos" => array:3 [ "EPUB" => 303 "HTML" => 2579 "PDF" => 547 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Cyclophosphamide-induced lupus flare?: the role of C4 and interferon-gamma in lupus flare" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "608" "paginaFinal" => "609" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S.J. Park, J.H. Kim, T.S. Ha, J.I. Shin" "autores" => array:4 [ 0 => array:2 [ "Iniciales" => "S.J." "apellidos" => "Park" ] 1 => array:2 [ "Iniciales" => "J.H." "apellidos" => "Kim" ] 2 => array:2 [ "Iniciales" => "T.S." "apellidos" => "Ha" ] 3 => array:2 [ "Iniciales" => "J.I." "apellidos" => "Shin" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X0211699511052458" "doi" => "10.3265/Nefrologia.pre2011.Jun.10942" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511052458?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052455?idApp=UINPBA000064" "url" => "/20132514/0000003100000005/v0_201502091634/X2013251411052455/v0_201502091634/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251411052471" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Jun.10983" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:607" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3388 "formatos" => array:3 [ "EPUB" => 288 "HTML" => 2583 "PDF" => 517 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Commentary on: Treatment of HCV infection in chronic kidney disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "607" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S.M. Alavian" "autores" => array:1 [ 0 => array:2 [ "Iniciales" => "S.M." "apellidos" => "Alavian" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X0211699511052474" "doi" => "10.3265/Nefrologia.pre2011.Jun.10983" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511052474?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052471?idApp=UINPBA000064" "url" => "/20132514/0000003100000005/v0_201502091634/X2013251411052471/v0_201502091634/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Response to the comment made on Treatment of HCV infection in chronic kidney disease" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "607" "paginaFinal" => "608" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Rebeca García Agudo, R. García Agudo, Sami Aoufi Rabih, S. Aoufi Rabih" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Rebeca" "apellidos" => "García Agudo" "email" => array:1 [ 0 => "rgarciaagudo@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:4 [ "Iniciales" => "R." "apellidos" => "García Agudo" "email" => array:1 [ 0 => "rgarciaagudo@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 2 => array:3 [ "nombre" => "Sami" "apellidos" => "Aoufi Rabih" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] ] 3 => array:3 [ "Iniciales" => "S." "apellidos" => "Aoufi Rabih" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Servicio de Nefrología, Complejo Hospitalario La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Servicio de Nefrología, Complejo Hospitalario La Mancha-Centro, Alcázar de San Juan, Ciudad Real, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] 2 => array:3 [ "entidad" => "Servicio de Aparato Digestivo, Complejo Hospitalario La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain, " "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] 3 => array:3 [ "entidad" => "Servicio de Aparato Digestivo, Complejo Hospitalario La Mancha-Centro, Alcázar de San Juan, Ciudad Real, " "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta al comentario sobre el Manejo de la infección por el virus de la hepatitis C en la enfermedad renal crónica" ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">To the Editor, </span></p><p class="elsevierStylePara">Haemodialysis units’ health policies and protocols are disparate meaning that prevalence of chronic hepatitis C infection is extremely variable in the haemodialysis population.<span class="elsevierStyleSup">1-3</span> In some countries classic infection factors, such as material contaminated due to reuse or blood transfusions, have been replaced by parenteral drug addiction or sexual transmission.<span class="elsevierStyleSup">4,5</span> It is not surprising that prevention is the most adequate and cost-effective control measure for these patients.</p><p class="elsevierStylePara">Treating chronic HCV before kidney transplantation is currently not an essential criteria for including HCV-positive patients on the transplant waiting list. However, risk of post-transplant chronic hepatitis C and the difficulty to treat it at this stage of the chronic kidney disease have been reported.<span class="elsevierStyleSup">6-11</span></p><p class="elsevierStylePara">Pegylated interferon and interferon + ribavirin are better than conventional interferon, according to clinical trials. However, the differences are small. Combining ribavirin and pegylated interferon requires close follow-up during haemodialysis given the severity of the secondary effects. It has increased the sustained viral response, although it is still less in the population without chronic kidney disease.<span class="elsevierStyleSup">12</span> This, along with the difficulty of treating patients with stages 4 and 5 chronic kidney disease in predialysis, highlights the importance of resolving the infection at early kidney disease stages.</p><p class="elsevierStylePara">Transjugular liver biopsy reduces the risks of bleeding associated with this procedure and the kidney patient, although there is little evidence in the literature.<span class="elsevierStyleSup">13,14</span> This technique also allows the hepatic venous pressure gradient to be measured, providing diagnostic and prognostic data.</p><p class="elsevierStylePara">Studies that determine whether the association of protease inhibitors (telaprevir, boceprevir) with interferon and ribavirin is safe for kidney patients and may increase viral response rates.</p>" "pdfFichero" => "P1-E524-S3360-A11119-EN.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:14 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Aoufi Rabih S, García Agudo R. Manejo de la infección por el VHC en la enfermedad renal crónica. Nefrologia 2011;31(3):260-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21407274" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Fissell RB, Bragg-Gresaham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004;65(6):2335-42. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15149347" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Sivapalasingam S, Malak SF, Sullivan JF, Lorch J, Sepkowitz KA. High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center. Infect Control Hosp Epidemiol 2002;23(6):319-24. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12083235" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Fölsch UR, Schmidt WE; PHV Study Group. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002;51(3):429-33. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12171969" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Huraib S, Al-Rashed R, Aldrees A, Aljefry M, Arif M, Al-Faleh FA. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 1995;10(4):470-4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7623989" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Hanafusa T, Ichikawa Y, Kishikawa H, Kyo M, Fukunishi T, Kokado Y, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998;66(4):471-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9734490" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Bruchfeld A, Wilczek H, Elinder CG. Hepatitis C infection, time in renal replacement therapy, and outcome after kidney transplantation. Transplantation 2004;78(5):745-50. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15371680" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Gentil MA, Rocha JL, Rodríguez-Algarra G, Pereira P, López R, Bernal G, et al. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1999;14(10):2455-60. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10528672" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Gheith OA, Saad MA, Hassan AA, A-Eldeeb S, Agroudy AE, Esaza H, et al. Hepatic dysfunction in kidney transplant recipients: prevalence and impact on graft and patient survival. Clin Exp Nephrol 2007;11(4):309-15. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18085393" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kamar N, Ribes D, Izopet J, Rostaing L. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCVpositive dialysis patients awaiting a kidney transplant. Transplantation 2006;82(7):853-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17038897" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Toth CM, Pascual M, Chung RT, Graeme-Cook F, Dienstag JL, Bhan AK, et al. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation 1998;66(9):1254-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9825826" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Fabrizi F, Dixit V, Martin P, Messa P. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials. J Viral Hepat 2010. doi: 10.1111/j.1365-2893.2010.01405.x. [Epub ahead of print]" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "De Paula Farra K, Carmo RA, De Figueiredo Antunes CM, Serufo JC, Nobre Júnior VA. Hepatitis C, HCV genotypes and hepatic siderosis in patients with chronic renal failure on haemodialysis in Brazil. Nephrol Dial Transplant 2007;22:2027-31. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17309883" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "García Agudo R, Aoufi Rabih S, Pérez Roldán F, Guzmán Ames F, González Carro P, Ruiz Carrillo F, Cuesta Domínguez R. El gradiente de presión venoso hepático y la biopsia hepática transyugular en la evaluación de los pacientes con insuficiencia renal y hepatopatía crónica. Nefrologia 2011;31(4):490-2. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21738254" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003100000005/v0_201502091634/X2013251411052463/v0_201502091634/en/main.assets" "Apartado" => array:4 [ "identificador" => "35439" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor - Comments on published articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003100000005/v0_201502091634/X2013251411052463/v0_201502091634/en/P1-E524-S3360-A11119-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052463?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 5 | 7 | 12 |
2024 October | 35 | 24 | 59 |
2024 September | 50 | 21 | 71 |
2024 August | 56 | 59 | 115 |
2024 July | 27 | 30 | 57 |
2024 June | 56 | 30 | 86 |
2024 May | 58 | 28 | 86 |
2024 April | 43 | 25 | 68 |
2024 March | 33 | 20 | 53 |
2024 February | 29 | 38 | 67 |
2024 January | 36 | 24 | 60 |
2023 December | 19 | 21 | 40 |
2023 November | 58 | 25 | 83 |
2023 October | 62 | 42 | 104 |
2023 September | 71 | 38 | 109 |
2023 August | 51 | 19 | 70 |
2023 July | 40 | 27 | 67 |
2023 June | 59 | 21 | 80 |
2023 May | 79 | 28 | 107 |
2023 April | 51 | 16 | 67 |
2023 March | 40 | 18 | 58 |
2023 February | 30 | 28 | 58 |
2023 January | 26 | 15 | 41 |
2022 December | 48 | 34 | 82 |
2022 November | 35 | 30 | 65 |
2022 October | 28 | 41 | 69 |
2022 September | 39 | 24 | 63 |
2022 August | 45 | 43 | 88 |
2022 July | 25 | 36 | 61 |
2022 June | 27 | 34 | 61 |
2022 May | 41 | 24 | 65 |
2022 April | 29 | 41 | 70 |
2022 March | 54 | 43 | 97 |
2022 February | 42 | 40 | 82 |
2022 January | 25 | 28 | 53 |
2021 December | 41 | 42 | 83 |
2021 November | 26 | 31 | 57 |
2021 October | 34 | 50 | 84 |
2021 September | 32 | 38 | 70 |
2021 August | 27 | 45 | 72 |
2021 July | 29 | 40 | 69 |
2021 June | 24 | 25 | 49 |
2021 May | 28 | 37 | 65 |
2021 April | 63 | 48 | 111 |
2021 March | 28 | 35 | 63 |
2021 February | 21 | 17 | 38 |
2021 January | 38 | 15 | 53 |
2020 December | 17 | 12 | 29 |
2020 November | 23 | 18 | 41 |
2020 October | 14 | 11 | 25 |
2020 September | 10 | 9 | 19 |
2020 August | 37 | 12 | 49 |
2020 July | 21 | 6 | 27 |
2020 June | 9 | 10 | 19 |
2020 May | 26 | 10 | 36 |
2020 April | 23 | 17 | 40 |
2020 March | 29 | 12 | 41 |
2020 February | 25 | 19 | 44 |
2020 January | 24 | 15 | 39 |
2019 December | 24 | 19 | 43 |
2019 November | 27 | 20 | 47 |
2019 October | 7 | 8 | 15 |
2019 September | 21 | 16 | 37 |
2019 August | 8 | 11 | 19 |
2019 July | 8 | 21 | 29 |
2019 June | 15 | 8 | 23 |
2019 May | 17 | 13 | 30 |
2019 April | 46 | 29 | 75 |
2019 March | 15 | 14 | 29 |
2019 February | 8 | 14 | 22 |
2019 January | 27 | 13 | 40 |
2018 December | 53 | 26 | 79 |
2018 November | 84 | 15 | 99 |
2018 October | 74 | 7 | 81 |
2018 September | 49 | 15 | 64 |
2018 August | 40 | 18 | 58 |
2018 July | 38 | 10 | 48 |
2018 June | 34 | 13 | 47 |
2018 May | 49 | 14 | 63 |
2018 April | 48 | 5 | 53 |
2018 March | 46 | 8 | 54 |
2018 February | 50 | 7 | 57 |
2018 January | 38 | 11 | 49 |
2017 December | 50 | 10 | 60 |
2017 November | 32 | 5 | 37 |
2017 October | 23 | 5 | 28 |
2017 September | 26 | 7 | 33 |
2017 August | 33 | 7 | 40 |
2017 July | 29 | 5 | 34 |
2017 June | 21 | 5 | 26 |
2017 May | 33 | 6 | 39 |
2017 April | 46 | 3 | 49 |
2017 March | 30 | 2 | 32 |
2017 February | 14 | 5 | 19 |
2017 January | 17 | 4 | 21 |
2016 December | 43 | 6 | 49 |
2016 November | 49 | 13 | 62 |
2016 October | 71 | 11 | 82 |
2016 September | 88 | 0 | 88 |
2016 August | 165 | 6 | 171 |
2016 July | 145 | 5 | 150 |
2016 June | 85 | 0 | 85 |
2016 May | 81 | 0 | 81 |
2016 April | 71 | 0 | 71 |
2016 March | 59 | 0 | 59 |
2016 February | 89 | 0 | 89 |
2016 January | 102 | 0 | 102 |
2015 December | 101 | 0 | 101 |
2015 November | 85 | 0 | 85 |
2015 October | 74 | 0 | 74 |
2015 September | 49 | 0 | 49 |
2015 August | 65 | 0 | 65 |
2015 July | 66 | 0 | 66 |
2015 June | 32 | 0 | 32 |
2015 May | 41 | 0 | 41 |
2015 April | 5 | 0 | 5 |